228 related articles for article (PubMed ID: 10226552)
41. 17 beta-hydroxysteroid oxidoreductase activity in intact cells significantly differs from classical enzymology analysis.
Castagnetta LA; Granata OM; Taibi G; Lo Casto M; Comito L; Oliveri G; Di Falco M; Carruba G
J Endocrinol; 1996 Sep; 150 Suppl():S73-8. PubMed ID: 8943790
[TBL] [Abstract][Full Text] [Related]
42. Required presence of both estrogen and pituitary factors for the growth of human breast cancer cells in athymic nude mice.
Leung CK; Shiu RP
Cancer Res; 1981 Feb; 41(2):546-51. PubMed ID: 7448802
[TBL] [Abstract][Full Text] [Related]
43. Selective estrogen enzyme modulator actions of melatonin in human breast cancer cells.
Gonzalez A; Cos S; Martinez-Campa C; Alonso-Gonzalez C; Sanchez-Mateos S; Mediavilla MD; Sanchez-Barcelo EJ
J Pineal Res; 2008 Aug; 45(1):86-92. PubMed ID: 18298468
[TBL] [Abstract][Full Text] [Related]
44. 1,25-Dihydroxyvitamin D3 and all-trans-retinoic acid sensitize breast cancer cells to chemotherapy-induced cell death.
Wang Q; Yang W; Uytingco MS; Christakos S; Wieder R
Cancer Res; 2000 Apr; 60(7):2040-8. PubMed ID: 10766196
[TBL] [Abstract][Full Text] [Related]
45. Idoxifene antagonizes estradiol-dependent MCF-7 breast cancer xenograft growth through sustained induction of apoptosis.
Johnston SR; Boeddinghaus IM; Riddler S; Haynes BP; Hardcastle IR; Rowlands M; Grimshaw R; Jarman M; Dowsett M
Cancer Res; 1999 Aug; 59(15):3646-51. PubMed ID: 10446976
[TBL] [Abstract][Full Text] [Related]
46. The role of aromatase and 17-beta-hydroxysteroid dehydrogenase type 1 mRNA expression in predicting the clinical outcome of human breast cancer.
Salhab M; Reed MJ; Al Sarakbi W; Jiang WG; Mokbel K
Breast Cancer Res Treat; 2006 Sep; 99(2):155-62. PubMed ID: 16541304
[TBL] [Abstract][Full Text] [Related]
47. Inhibition of estrone sulfatase activity by estrone-3-methylthiophosphonate: a potential therapeutic agent in breast cancer.
Duncan L; Purohit A; Howarth NM; Potter BV; Reed MJ
Cancer Res; 1993 Jan; 53(2):298-303. PubMed ID: 8417823
[TBL] [Abstract][Full Text] [Related]
48. Modulation of prolactin receptors (PRL-R) by lactogenic and steroid hormones in human breast cancer cells in long-term tissue culture (T-47D).
Leroy-Martin B; Peyrat JP
Anticancer Res; 1989; 9(3):631-6. PubMed ID: 2764510
[TBL] [Abstract][Full Text] [Related]
49. 13-cis retinoic acid and all-trans retinoic acid in the regulation of the proliferation and survival of human breast cancer cell line MCF-7.
Czeczuga-Semeniuk E; Wolczyński S; Dziecioł J; Dabrowska M; Anchim T; Tomaszewska I
Cell Mol Biol Lett; 2001; 6(4):925-39. PubMed ID: 11753438
[TBL] [Abstract][Full Text] [Related]
50. The regulatory effect of tamoxifen on fibronectin expression in estrogen-dependent MCF-7 breast carcinoma cells.
Horii Y; Takei H; Koibuchi Y; Horiguchi J; Maemura M; Iino Y; Morishita Y
Oncol Rep; 2006 May; 15(5):1191-5. PubMed ID: 16596185
[TBL] [Abstract][Full Text] [Related]
51. Estrone/17beta-estradiol conversion to, and tumor necrosis factor inhibition by, estrogen metabolites in synovial cells of patients with rheumatoid arthritis and patients with osteoarthritis.
Schmidt M; Hartung R; Capellino S; Cutolo M; Pfeifer-Leeg A; Straub RH
Arthritis Rheum; 2009 Oct; 60(10):2913-22. PubMed ID: 19790073
[TBL] [Abstract][Full Text] [Related]
52. 17beta-hydroxysteroid dehydrogenases in human breast cancer.
Nagasaki S; Miki Y; Akahira J; Suzuki T; Sasano H
Ann N Y Acad Sci; 2009 Feb; 1155():25-32. PubMed ID: 19250189
[TBL] [Abstract][Full Text] [Related]
53. Effect of tibolone and its principal metabolites (3α- and 3β-hydroxy, 3α-sulfate, and 4-ene derivatives) on estrone sulfatase activity in normal and cancerous human breast tissue.
Chetrite GS; Cortes-Prieto J; Pasqualini JR
Horm Mol Biol Clin Investig; 2011 Dec; 8(3):491-8. PubMed ID: 25961347
[TBL] [Abstract][Full Text] [Related]
54. [Evaluation of 17-beta-hydroxysteroid dehydrogenase activity as a marker of the hormone dependence of breast cancers].
Fournier S; Allali F; Durand JC; Sterkers N; Debertrand P; Diebold N; Martin PM; Kuttenn F; Mauvais-Jarvis P
Pathol Biol (Paris); 1985 Jun; 33(6):659-64. PubMed ID: 2995904
[TBL] [Abstract][Full Text] [Related]
55. Apoptosis and proliferation in breast cancer cells, cultured in vitro: effects of SERMs.
Werner HM; Franke HR; Vermes I
Climacteric; 2005 Sep; 8(3):294-9. PubMed ID: 16390761
[TBL] [Abstract][Full Text] [Related]
56. The selective estrogen enzyme modulators in breast cancer: a review.
Pasqualini JR
Biochim Biophys Acta; 2004 Jun; 1654(2):123-43. PubMed ID: 15172700
[TBL] [Abstract][Full Text] [Related]
57. Estrone sulfate-sulfatase and 17 beta-hydroxysteroid dehydrogenase activities: a hypothesis for their role in the evolution of human breast cancer from hormone-dependence to hormone-independence.
Pasqualini JR; Chetrite G; Nguyen BL; Maloche C; Delalonde L; Talbi M; Feinstein MC; Blacker C; Botella J; Paris J
J Steroid Biochem Mol Biol; 1995 Jun; 53(1-6):407-12. PubMed ID: 7626488
[TBL] [Abstract][Full Text] [Related]
58. Correlation of estrogen sulfotransferase activity and proliferation in normal and carcinomatous human breast. A hypothesis.
Pasqualini JR; Chetrite GS
Anticancer Res; 2007; 27(5A):3219-25. PubMed ID: 17970064
[TBL] [Abstract][Full Text] [Related]
59. Concentration-dependent mitogenic and antiproliferative actions of 2-methoxyestradiol in estrogen receptor-positive human breast cancer cells.
Liu ZJ; Zhu BT
J Steroid Biochem Mol Biol; 2004 Mar; 88(3):265-75. PubMed ID: 15120420
[TBL] [Abstract][Full Text] [Related]
60. Benefits of complete polyamine deprivation in hormone responsive and hormone resistant MCF-7 human breast adenocarcinoma in vivo.
Leveque J; Foucher F; Havouis R; Desury D; Grall JY; Moulinoux JP
Anticancer Res; 2000; 20(1A):97-101. PubMed ID: 10769640
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
